查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553686

北美OTC透明质酸市场规模、份额和趋势分析报告：按产品、销售管道、国家、细分市场预测，2024-2030年

North America OTC Hyaluronic Acid Market Size, Share & Trends Analysis Report By Product (Dermatology (Moisturizers), Orthopedics), By Sales Channel (Online, Retail), By Country, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

北美OTC透明质酸市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，北美OTC透明质酸市场规模将达到102.9亿美元，预测期内复合年增长率为7.9%。

造成这一增长的因素之一是由于缺乏运动而导致肥胖人数增加、速食和酒精消费量增加，尤其是年轻人数量增加。

透明质酸 (HA) 的整形外科应用预计将成为该市场中最有利可图的领域。这是由于越来越多的针对 60 岁以上患有类风湿性关节炎和骨关节炎等各种关节疾病的人群，以及针对这一人群的新产品的推出。此外，由于关节炎相关住院人数的增加以及医疗保健专业人员对透明质酸卓越理化特性的认识不断提高，预计需求将受到推动。 20 至 65 岁之间的女性人口不断增加，以及人们对透明质酸益处的认识不断提高，是推动皮肤科手术中透明质酸需求激增的关键因素。

透明质酸 (HA) 刺激蛋白质的合成，这些蛋白质在支持皮肤结构和胶原蛋白发挥重要作用。对透明质酸作为外用护肤霜和精华液的需求不断增长，加上该领域的市场参与企业不断增加，预示着未来的成长。人们对护肤品中透明质酸的益处的认识不断提高，与胶原蛋白相比，透明质酸更能有效地渗透真皮，预计也将推动市场趋势。根据多方报道，美国女性总人口中约27%属于45岁至65岁年龄段，是抗皱霜需求激增的关键因素之一。

主要参与者包括资生堂、Lindberg Nutrition &GeniusCentral Systems、Nature's Way Products, LLC、NOW Foods、NeoCell Corporation、Source Naturals, Inc、Doctors Best、derma e 和 Earth Science Naturals。

北美非处方透明质酸市场报告亮点：

  • 按产品划分，皮肤科细分市场在 2023 年占据最大的市场收益占有率。该细分市场的快速增长是由于各种手术中对透明质酸填充剂的需求激增以及皱纹、痤疮和疤痕等皮肤问题病例的增加而推动的。
  • 由于肌肉骨骼疾病、运动伤害和骨折的增加，整形外科预计将在预测期内实现最快的增长。
  • 以销售管道来看，零售占最大市场收益占有率，2023年将达83.7%。预计推动市场的主要因素是在药局、百货公司和超级市场容易买到化妆品和联合补充品。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章北美OTC透明质酸市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 北美OTC透明质酸市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 北美OTC透明质酸市场：依产品估算及趋势分析

  • 细分仪表板
  • 北美非处方透明质酸市场：2023 年和 2030 年产品变化分析
  • 皮肤科
  • 整形外科

第五章 北美OTC玻尿酸市场：依销售管道估算及趋势分析

  • 细分仪表板
  • 北美OTC透明质酸市场：2023年及2030年销售管道波动分析
  • 零售
  • 在线的

第六章 北美OTC玻尿酸市场：区域预估及趋势分析

  • 2023 年和 2030 年北美非处方透明质酸市场占有率（按国家/地区）
  • 美国
    • 加州
    • 德克萨斯
    • 纽约
    • 佛罗里达
    • 其他州
  • 加拿大
  • 墨西哥

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Shiseido Company
    • Lindberg Nutrition Products
    • Nature's Way
    • Now Foods
    • NeoCell Corporation
    • Source Naturals, Inc.
    • Doctor's Best
    • Derma E
    • Earth Science
简介目录
Product Code: GVR-1-68038-435-2

North America OTC Hyaluronic Acid Market Growth & Trends:

The North America OTC hyaluronic acid market size is expected to reach USD 10.29 billion by 2030, registering a CAGR of 7.9% during the forecast period, according to a new report by Grand View Research, Inc. The increasing number of obese people owing to the lack of physical activity and higher consumption of fast food & alcohol, especially by the younger population are some of the factors accounting for growth.

Orthopedic applications of hyaluronic acid (HA) are expected to emerge as the most lucrative segment of this market. This can be attributed to the growing target audience above 60 years, suffering from various joint disorders such as rheumatoid arthritis and osteoarthritis coupled with the introduction of new products catering to this population subset. In addition, an increase in the number of arthritis-related hospitalization cases and growing awareness amongst the healthcare professionals regarding excellent physiochemical properties of hyaluronic acid is expected to drive the demand. The growing population of women between 20 and 65 years of age and increasing awareness regarding the benefits of HA is some of the crucial factors driving the surging demand for hyaluronic acid in dermatological procedures.

Hyaluronic acid (HA) stimulates the synthesis of a protein that plays a crucial role in supporting skin structure and collagen, which declines with age leading to wrinkling formation. The growing demand for HA as a topical skin cream or serum coupled with the increasing presence of market participants in this sector is indicative of future growth. The rising awareness regarding the benefits of HA in skincare products for penetrating the dermis more effectively as compared to collagen is also anticipated to propel the market trend. According to various reports, approximately 27% of the total U.S. women population belong to the age group of 45 to 65 years, which is one of the crucial factors responsible for the surging demand for anti-wrinkle creams.

Some of the key players are Shiseido Co., Ltd.; Lindberg Nutrition & GeniusCentral Systems; Nature's Way Products, LLC; NOW Foods; NeoCell Corporation; Source Naturals, Inc.; Doctors Best; derma e; and Earth Science Naturals.

North America OTC Hyaluronic Acid Market Report Highlights:

  • By product, Dermatology segment accounted for the largest market revenue share in 2023. The rapid growth of this segment is being fueled by a surge in demand for HA-based fillers for various procedures, as well as a rise in cases of skin concerns such as wrinkles, acne, and scarring.
  • Orthopedics is expected to register the fastest growth during the forecast period, driven by the rise of musculoskeletal disorders, sports injuries, and fractures.
  • By sales channel, retail accounted for the largest market revenue share of 83.7% in 2023. Main factors that is anticipated to drive the market is the easy access to cosmetics and joint supplements in drug stores, departmental stores, and supermarkets.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America OTC Hyaluronic Acid Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. North America OTC Hyaluronic Acid Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. North America OTC Hyaluronic Acid Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America OTC Hyaluronic Acid Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Dermatology
    • 4.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Moisturizers
      • 4.3.2.1. Moisturizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Anti-wrinkle Creme
      • 4.3.3.1. Anti-wrinkle Creme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Orthopedics
    • 4.4.1. Orthopedics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America OTC Hyaluronic Acid Market: Sales Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America OTC Hyaluronic Acid Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Retail
    • 5.3.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Online
    • 5.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America OTC Hyaluronic Acid Market: Regional Estimates & Trend Analysis

  • 6.1. North America OTC Hyaluronic Acid Market Share, By Country, 2023 & 2030 (USD Million)
  • 6.2. U.S.
    • 6.2.1. U.S. OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. California
      • 6.2.2.1. California OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Texas
      • 6.2.3.1. Texas OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. New York
      • 6.2.4.1. New York OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5. Florida
      • 6.2.5.1. Florida OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6. Other States
      • 6.2.6.1. Other States OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Canada
    • 6.3.1. Canada North America OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Mexico
    • 6.4.1. Mexico North America OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Shiseido Company
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Lindberg Nutrition Products
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Nature's Way
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Now Foods
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. NeoCell Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. Source Naturals, Inc.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Doctor's Best
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Derma E
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Earth Science
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives